Literature DB >> 35059899

Bioinformatics analysis of recurrent deletion regions in neuroblastoma.

Hasan Onur Caglar1.   

Abstract

Neuroblastoma (NB) is the most common extra-cranial solid tumor in childhood. Very few genes in recurrent deletion regions have been identified as tumor suppressors for NB, and interactions among proteins encoded by genes in these regions have been overlooked. This study aims to identify possible tumor suppressor genes located within regions commonly deleted in NB tumors and to show possible interaction network of proteins encoded by genes in these regions by bioinformatics analysis. The genes localized in the recurrent deletion regions were identified using the Ensembl BioMart web-tool. GSE1824 microarray dataset was analyzed to determine downregulated differently expressed genes (dDEGs) selected from deletion regions using Orange Canvas software. The DAVID v6.8 tool and Reactome database were used to perform gene ontology and pathway enrichment analysis, respectively. The protein-protein interaction (PPI) network and sub-module analysis were conducted by STRING database and Cytoscape plugin MCODE software, respectively. Copy number variation status and mutations of hub genes were examined in TARGET neuroblastoma dataset using UCSC Xena platform. Biological processes of genes were specific to chromosomes. The 219 genes selected from these regions were found to be downregulated. A PPI network was constructed for dDEGs. Copy number losses and mutations were observed for hub genes. Hub genes identified in the current study may act as tumor suppressors in NB tumorigenesis. Disruption of protein-protein interaction network consisting of proteins encoded by genes on various recurrent deletion regions may give rise to NB by interrupting gene regulatory network orchestrating neural crest formation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioinformatics; Chromosome deletion; Neuroblastoma; Tumor suppressor genes

Mesh:

Substances:

Year:  2022        PMID: 35059899     DOI: 10.1007/s12032-021-01639-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  67 in total

1.  Regulation of Msx genes by a Bmp gradient is essential for neural crest specification.

Authors:  Celeste Tribulo; Manuel J Aybar; Vu H Nguyen; Mary C Mullins; Roberto Mayor
Journal:  Development       Date:  2003-11-19       Impact factor: 6.868

2.  Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction.

Authors:  Anne-Hélène Monsoro-Burq; Estee Wang; Richard Harland
Journal:  Dev Cell       Date:  2005-02       Impact factor: 12.270

Review 3.  A gene regulatory network orchestrates neural crest formation.

Authors:  Tatjana Sauka-Spengler; Marianne Bronner-Fraser
Journal:  Nat Rev Mol Cell Biol       Date:  2008-06-04       Impact factor: 94.444

4.  Specification of the neural crest occurs during gastrulation and requires Pax7.

Authors:  Martín L Basch; Marianne Bronner-Fraser; Martín I García-Castro
Journal:  Nature       Date:  2006-05-11       Impact factor: 49.962

Review 5.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

6.  High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.

Authors:  Helena Carén; Hanna Kryh; Maria Nethander; Rose-Marie Sjöberg; Catarina Träger; Staffan Nilsson; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-09       Impact factor: 11.205

Review 7.  Neuroblastoma.

Authors:  Katherine K Matthay; John M Maris; Gudrun Schleiermacher; Akira Nakagawara; Crystal L Mackall; Lisa Diller; William A Weiss
Journal:  Nat Rev Dis Primers       Date:  2016-11-10       Impact factor: 52.329

Review 8.  Neuroblastoma.

Authors:  Akira Nakagawara; Yuanyuan Li; Hideki Izumi; Katsumi Muramori; Hiroko Inada; Masanori Nishi
Journal:  Jpn J Clin Oncol       Date:  2018-03-01       Impact factor: 3.019

9.  Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification.

Authors:  Sven Bilke; Qing-Rong Chen; Jun S Wei; Javed Khan
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

Review 10.  Molecular targeting therapies for neuroblastoma: Progress and challenges.

Authors:  Atif Zafar; Wei Wang; Gang Liu; Xinjie Wang; Wa Xian; Frank McKeon; Jennifer Foster; Jia Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2020-11-06       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.